News - Botox

Filter

Current filters:

Botox

Popular Filters

UK’s MHRA approves Botox for treatment of ankle disability in stroke survivors

04-02-2014

Allergan says that Botox has been approved by the UK’s Medicines and Healthcare Products Regulatory…

AllerganBotoxPharmaceuticalRegulationUK

Allergan closes $65 million deal with Medytox

Allergan closes $65 million deal with Medytox

09-01-2014

This week US drugmaker Allergan (NYSE: AGN) announced that it has closed a $65 million license agreement…

AllerganAsia-PacificBotoxDermatologicalsLicensingMedytoxPharmaceuticalRegulationUKUSA

UK MHRA licenses Allergan's Botox for use in patients with overactive bladder

11-09-2013

Botox (botulinum toxin type A), from US drugmaker Allergan (NYSE: AGN), has been licensed by the UK Medicines…

AllerganBotoxEuropeGenito-urinaryPharmaceuticalRegulation

GSK executives investigated in China over bribery and tax-related crimes

11-07-2013

Executives at UK pharma giant GlaxoSmithKline (LSE: GSK) in China are being investigated on suspicion…

Asia-PacificBotoxGlaxoSmithKlinePharmaceuticalPricing

FDA approves Allergan's Botox for OAB and NuPathe's Zecuity for migraine

21-01-2013

US drugmaker Allergan (NYSE: AGN) says that the US Food and Drug Administration has approved its Botox…

AllerganBotoxGenito-urinaryNeurologicalNorth AmericaNuPathePharmaceuticalRegulationZecuity

Migraine drug sales to grow to $5.8 billion in 2021 in major markets

18-11-2012

Despite a decline in sales owing to the generic entry of most triptans, the launch of emerging acute…

AllerganBotoxCoLucidGenericsGloballasmiditanLevadexMAP PharmaceuticalsMarkets & MarketingPharmaceuticalResearch

UK's NICE negative on Sanofi's Jevtana, but backs Botox for migraine

11-05-2012

Confirming previous negative guidance (The Pharma Letter January 12), UK drugs watchdog the National…

AllerganBotoxEuropeJevtanaNeurologicalOncologyPharmaceuticalPricingRegulationSanofi

Allergan wins over EU trade marks for Botolist and Botocyl

10-05-2012

The was good news yesterday for USA-based Allergan (NYSE: AGN) when the European Court of Justice confirmed…

AllerganBotocylBotolistBotoxEuropePatentsPharmaceutical

Botox shows efficacy in idiopathic overactive bladder, says Allergan

29-03-2012

USA-based Allergan (NYSE: AGN) announced that two Phase III clinical trials of Botox (onabotulinumtoxinA),…

AllerganBotoxGenito-urinaryPharmaceuticalRegulationResearch

US court rules in favor of Allergan in Merz Botox law suit

13-03-2012

US drugmaker Allergan (NYSE: AGN) revealed that US District Judge Andrew. Guilford, after conducting…

AllerganBotoxBotox CosmeticEuropeLegalMarkets & MarketingMerz PharmaceuticalsNorth AmericaPharmaceuticalXeomin

UK NICE asks for more data on Tarceva, and Botox for migraine

17-02-2012

UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) today issued new draft…

AllerganBotoxEuropeNeurologicalOncologyPharmaceuticalPricingRegulationRocheTarceva

Allergan gets US FDA nod for Botox to treat form of urinary incontinence

25-08-2011

There was a boost for US specialty drug firm Allergan (NYSE: AGN) yesterday when the company revealed…

AllerganBotoxNeurologicalNorth AmericaPharmaceuticalRegulation

Allergan’s Botox gets positive European opinion for urinary incontinence

09-08-2011

US specialty drug firm Allergan (NYSE: AGN) has received a positive opinion from the Irish Medicines…

AllerganBotoxEuropeGastro-intestinalsPharmaceuticalRegulation

Back to top